| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |